Valeant: Stop Looking in the Rearview Mirror!

One team of analysts initiated a number of specialty pharma stocks, including Valeant, with Outperform ratings today. They argue that it’s time to look forward, not back.
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>